Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

NET PROFIT (x1000 NOK)

EMPLOYEES

Share

Annexin Pharmaceuticals AB (publ)

Closing information (x1000 NOK)

Closing information 2022/12 2021/12 2020/12
Turnover 0 Equal arrow 0 Equal arrow 0
Financial expenses 2 More Arrow 1,813 Less Arrow 527
Earnings before taxes -38,523 Less Arrow -50,850 More Arrow -46,346
EBITDA -38,521 Less Arrow -49,964 More Arrow -45,819
Total assets 34,695 More Arrow 51,478 Less Arrow 26,356
Current assets 31,830 More Arrow 49,460 Less Arrow 23,987
Current liabilities 6,173 Less Arrow 5,909 Less Arrow 4,735
Equity capital 28,522 More Arrow 45,569 Less Arrow 21,620
- share capital 2,419 More Arrow 26,768 Less Arrow 18,525
Employees (average) 5 Equal arrow 5 Less Arrow 4

Financial ratios

Fiscal year 2022/12 2021/12 2020/12
Solvency 82.2% More Arrow 88.5% Less Arrow 82.0%
Turnover per employee 0 Equal arrow 0 Equal arrow 0
Profit as a percentage of turnover
Return on assets (ROA) -111.0% More Arrow -95.3% Less Arrow -173.8%
Current ratio 515.6% More Arrow 837.0% Less Arrow 506.6%
Return on equity (ROE) -135.1% More Arrow -111.6% Less Arrow -214.4%
Change turnover 0 Equal arrow 0 Equal arrow 0
Change turnover %
Chg. No. of employees 0 More Arrow 1 Less Arrow 0
Chg. No. of employees % 0% More Arrow 25% Less Arrow 0%

Total value of public sale

Fiscal year 2022/12 2021/12 2020/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.